ISSN Portal
The Keepers Registry (preservation)
SHERPA/RoMEO (access policies)
The Lancet Rheumatology
container_b7fopi45ozezrdbxx3l2zcy4x4
Elsevier BV
Homepage URLs
https://www.sciencedirect.com/journal/the-lancet-rheumatology |
https://www.thelancet.com/journals/lanrhe/home |
Example Publications
Identification of distinct subgroups of Sjögren's disease by cluster analysis based on clinical and biological manifestations: data from the cross-sectional Paris-Saclay and the prospective ASSESS cohorts
Yann Nguyen, Gaëtane Nocturne, Julien Henry, Wan-Fai Ng, Rakiba Belkhir, Frédéric Desmoulins, Elisabeth Bergé, Jacques Morel, Aleth Perdriger, Emmanuelle Dernis, Valérie Devauchelle-Pensec, Damien Sène
(+11 others)
2024
|
The Lancet Rheumatology
doi:10.1016/s2665-9913(23)00340-5 pmcid:PMC10949202
Antibody prevalence after three or more COVID-19 vaccine doses in individuals who are immunosuppressed in the UK: a cross-sectional study from MELODY
Fiona A Pearce, Sean H Lim, Mary Bythell, Peter Lanyon, Rachel Hogg, Adam Taylor, Gillian Powter, Graham S Cooke, Helen Ward, Joseph Chilcot, Helen Thomas, Lisa Mumford
(+4 others)
2023
|
The Lancet Rheumatology
doi:10.1016/s2665-9913(23)00160-1 pmid:38251578
Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: a propensity-weighted cohort study
Samuel Channon-Wells, Ortensia Vito, Andrew J McArdle, Eleanor G Seaby, Harsita Patel, Priyen Shah, Ekaterina Pazukhina, Clare Wilson, Claire Broderick, Giselle D'Souza, Ilana Keren, Ruud G Nijman
(+468 others)
2023
|
The Lancet Rheumatology
doi:10.1016/s2665-9913(23)00029-2 pmcid:PMC9949883
Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a single-centre cohort study
Md Yuzaiful Md Yusof, Jack Arnold, Benazir Saleem, Claire Vandevelde, Shouvik Dass, Sinisa Savic, Edward M Vital, Paul Emery
2023
|
The Lancet Rheumatology
doi:10.1016/s2665-9913(23)00004-8 pmcid:PMC9873269
Identification of biomarkers to stratify response to B-cell-targeted therapies in systemic lupus erythematosus: an exploratory analysis of a randomised controlled trial
Muhammad Shipa, Liliana R Santos, Dao X Nguyen, Andrew Embleton-Thirsk, Mariea Parvaz, Lauren L Heptinstall, Ruth J Pepper, David A Isenberg, Caroline Gordon, Michael R Ehrenstein
2022
|
The Lancet Rheumatology
doi:10.1016/s2665-9913(22)00332-0 pmcid:PMC9894756